Mid-Atlantic Bio Therapeutics Inc is categorized under Biological Products Manufacturers in Doylestown, PA and active since 2011.
Mid-Atlantic Bio Therapeutics Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact David Horn at the company’s single location by writing to 3805 Old Easton Road, Doylestown, Pennsylvania PA 18902 or by phoning (215) 266-2301. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mid-Atlantic Bio Therapeutics Inc |
| Contact Person: | David Horn |
| Address: | 3805 Old Easton Road, Doylestown, Pennsylvania 18902 |
| Phone Number: | (215) 266-2301 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Mid-Atlantic Bio Therapeutics Inc was started in 2011 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Horn for inquiries that concern Mid-Atlantic Bio Therapeutics Inc by calling the company number (215) 266-2301, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid-Atlantic Bio Therapeutics Inc can be found at the coordinates 40.333189,-75.12617 as well as the street address 3805 Old Easton Road in Doylestown, Pennsylvania 18902.
For its online presence, you may visit Mid-Atlantic Bio Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.